Ventricular Dysfunction, Left: Clinical Trials

314 trials for Ventricular Dysfunction, Left, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

150 completed, 49 unknown, 48 recruiting, 23 terminated. 88 Not applicable, 34 Phase 2, 33 Phase 3, 22 Phase 4, 12 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable88Completed 36, Unknown 14, Recruiting 12, Terminated 9, Active not recruiting 8, Not yet recruiting 6, Withdrawn 2, Enrolling by invitation 1
Phase 234Completed 16, Terminated 7, Unknown 5, Recruiting 4, Not yet recruiting 1, Withdrawn 1
Phase 333Completed 19, Recruiting 6, Terminated 4, Unknown 2, Active not recruiting 1, Not yet recruiting 1
Phase 422Completed 13, Not yet recruiting 3, Recruiting 3, Unknown 3
Phase 112Completed 5, Unknown 3, Terminated 2, Withdrawn 2

Follow Ventricular Dysfunction, Left: new trials by email Literature Review of Ventricular Dysfunction, Left trials Research Report on Ventricular Dysfunction, Left

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Monitoring for CardioToxicity Using WeArable deVices While Undergoing cancEr Treatments (MCT-WAVE)
Mobile Cardiac Telemetry, Wearable Cardiac Monitor - Cardiotoxicity, Cancer
Not applicableNot yet recruitingUniversity of Minnesota722026-10-292026-10-06
Sacubitril/Valsartan Versus Valsartan Alone on Left Atrial Volume Index in Hypertensive Patients
Sacubitril / Valsartan, Valsartan - Hypertension, Left Ventricular Diastolic Dysfunction
Not applicableNot yet recruitingUniversity of Health Sciences Lahore1022026-10-012026-10-02
Inflammatory Disease Biobank for Immunophenotyping and Cardiovascular Research
Pericarditis, Tako-TSUBO Cardiomyopathy
Not yet recruitingAssistance Publique - Hôpitaux de Paris3002026-09-012026-08-10
Federated Learning for Point-of-Care Cardiac Ultrasound
Focused Cardiac Point-of-Care Ultrasonography, FL-POCUS Federated Machine-Learning Analysis System - Ventricular Dysfunction, Left, Ventricular Function, Left
Enrolling by invitationTruway Health, Inc.30002026-08-312026-09-02
AI-Based Cardiac Analysis Using 12-Lead and 1-Lead ECG
SmartECG-EF - Heart Failure, Atrial Fibrillation (AF)
Not yet recruitingInha University Hospital3002026-08-302026-09-28
Menopausal Hormone Therapy And Left Ventricular Function
Menopausal Hormone Therapy - Menopause, Left Ventricular Dysfunction
RecruitingMayo Clinic502026-08-262026-08-27
STEPwise De-escalation and Optimizing Withdrawal of ARNI and SGLT2i in Normalized Heart Failure
Stepwise Withdrawal of ARNI and SGLT2i, Continued Guideline-Directed Medical Therapy - Heart Failure With Reduced Ejection Fraction, Heart Failure
Phase 4RecruitingKyungsub Song802026-08-122026-09-02
Midodrine in Heart Failure With Reduced Ejection Fraction With Hypotension
Midodrine Oral Tablet - Heart Failure With Reduced Ejection Fraction, Hypotension
Phase 2 / Phase 3RecruitingOttawa Heart Institute Research Corporation562026-08-072026-09-08
PASCAL Precision-GDMT Registry
Tricuspid Insufficiency, Tricuspid Regurgitation (TR)
Not yet recruitingCeric Sàrl502026-08-012026-05-13
Micro-axial Flow Pump-Supported PCI in Complex Coronary Artery Disease With Ischemic LV Dysfunction
Microaxial pump-supported PCI, Optimal medical therapy (OMT) - Coronary Artery Disease (CAD)
Not applicableNot yet recruitingChina National Center for Cardiovascular Diseases4522026-08-012026-07-01
Importance of Point-of-Care Ultrasound for Early Detection of Valvular and Cardiac Diseases (IMPROVE)
Kosmos Torso-One AI-guided Point-of-Care Ultrasound (EchoNous, Inc.) - Valvular Heart Disease Patients, Aortic Stenosis
Not applicableNot yet recruitingUniversity of Texas Southwestern Medical Center10882026-08-012026-08-17
Sotagliflozin as Prevention of Anthracycline-Related Cardiotoxicity
Sotagliflozin, Placebo - Anthracycline-induced Cardiotoxicity, Lymphoma
Phase 2Not yet recruitingIcahn School of Medicine at Mount Sinai602026-07-012026-05-07
The Use of Single-Beat TE-e' in Evaluation of Left Atrial Pressure in Critically Ill Patients: The TELAP-ICU Trial
Echocardiography - Critical Illness, Elevated Left Atrial Pressure
RecruitingQueen Mary Hospital, Hong Kong502026-07-012026-09-15
CHIP-CC Registry: A Prospective Multicenter Registry of Complex High-Risk PCI in China
Percutaneous Coronary Intervention, Mechanical Circulatory Support - Coronary Artery Disease, High Risk PCI
Not yet recruitingGuofeng Gao10002026-06-012026-05-12
A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
Finerenone (Kerendia, BAY94-8862) - Left Ventricular Systolic Dysfunction, Heart Failure (Pediatric)
Phase 3RecruitingBayer1172026-06-012026-10-15
Assement of Left Ventricular Function Before Decannulation in Cardiac Surgery :Visual Estimation vs TEE
Intraoperative Left Ventricular Function Assessment - Cardiopulmonary Bypass Surgery, Left Ventricular Dysfunction
RecruitingAtaturk University702026-01-012026-09-04
AI-Enabled Electrocardiogram-Guided Guideline-Directed Medical Therapy on Incident Left Ventricular Dysfunction: A Target Trial Emulation Study
Guideline-directed medical therapies - Left Ventricular (LV) Systolic Dysfunction
Not applicableRecruitingTri-Service General Hospital (TSGH)50002026-01-012026-01-21
Preoperative Maltodextrin's Effect on Cardiac Function in Cardiac Surgery
Maltodextrin solution, Placebo solution - Left Ventricular Dysfunction, Quality of Recovery
Phase 4Not yet recruitingJewish General Hospital702025-12-012025-02-24
EACVI Study on Multimodality Cardiovascular Imaging of Inflammatory Cardiovascular Diseases
observational study - Myocarditis, ANCA Associated Vasculitis
RecruitingAssistance Publique - Hôpitaux de Paris50002025-11-192026-06-05
A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
Finerenone (Kerendia, BAY94-8862), Placebo - Left Ventricular Systolic Dysfunction, Heart Failure (Pediatric)
Phase 3RecruitingBayer1112025-11-192026-10-15

Showing 20 of 314. Sign in to see all of them.

Narrower conditions

Heart Failure (81)  ·  Takotsubo Cardiomyopathy (63)  ·  Myocardial Infarction (26)  ·  Coronary Artery Disease (17)  ·  Heart Diseases (16)  ·  Cardiovascular Diseases (14)  ·  Heart Failure, Systolic (12)  ·  Cardiomyopathies (11)  ·  Hypertension, Pulmonary (10)  ·  Acute Coronary Syndrome (9)  ·  Arrhythmias, Cardiac (9)  ·  Mitral Valve Insufficiency (9)  ·  ST Elevation Myocardial Infarction (9)  ·  Cardiotoxicity (8)

Broader conditions

Ventricular Dysfunction (306)  ·  Cardiovascular Diseases (300)  ·  Heart Diseases (298)  ·  Pathological Conditions, Signs and Symptoms (119)  ·  Pathologic Processes (104)  ·  Vascular Diseases (92)  ·  Cardiomyopathies (65)  ·  Myocardial Ischemia (57)  ·  Ischemia (37)  ·  Necrosis (36)  ·  Infarction (35)  ·  Nervous System Diseases (25)  ·  Respiratory Tract Diseases (23)  ·  Nutritional and Metabolic Diseases (19)

Interventions

Echocardiography (17)  ·  Valsartan (6)  ·  sacubitril and valsartan sodium hydrate drug combination (5)  ·  Magnetic Resonance Spectroscopy (4)  ·  Simendan (4)  ·  dapagliflozin (4)  ·  Cardiac Resynchronization Therapy (3)  ·  Carvedilol (3)  ·  Control Groups (3)  ·  Electrocardiography (3)  ·  Metoprolol (3)  ·  apixaban (3)  ·  riociguat (3)  ·  Adenosine (2)  ·  Adrenergic beta-Antagonists (2)

Sponsors

Assistance Publique - Hôpitaux de Paris (9)  ·  Mayo Clinic (7)  ·  University of Aberdeen (6)  ·  Bayer (5)  ·  Eko Devices, Inc. (4)  ·  Medtronic Cardiac Rhythm and Heart Failure (4)  ·  National Defense Medical Center, Taiwan (4)  ·  Sahlgrenska University Hospital (4)  ·  The University of Texas Health Science Center, Houston (4)  ·  University of Edinburgh (4)  ·  Yonsei University (4)  ·  Abbott Medical Devices (3)  ·  Abiomed Inc. (3)  ·  Cedars-Sinai Medical Center (3)  ·  Heart Care Foundation (3)

Countries

United States (93)  ·  United Kingdom (36)  ·  Germany (32)  ·  Italy (30)  ·  France (24)  ·  Canada (22)  ·  China (16)  ·  Netherlands (15)  ·  Sweden (15)  ·  Czechia (14)  ·  Denmark (14)  ·  South Korea (13)  ·  Switzerland (13)  ·  Spain (12)  ·  Belgium (11)

Top investigators

Robert Simari, MD (4)  ·  Abhiram Prasad, MD (2)  ·  Cheng-Wei Liu, M.D. (2)  ·  Dana Dawson, MD, MRCP (2)  ·  Jonatan Oras, MD, PhD (2)  ·  Joseph B Selvanayagam, MBBS (2)  ·  Mattia Cattaneo, MD (2)  ·  Partho Sengupta, MD (2)  ·  Peter Goettel, MD (2)  ·  Rocco A Montone, MD, PhD (2)  ·  Roman E Batalov, M.D. (2)  ·  Sandeep Gulati, PhD (2)  ·  Tariel A Atabekov, Ph.D. (2)

Results publications

PMID 25136078, PMID 35861811, PMID 10093980, PMID 11069188, PMID 16034869, PMID 16086933, PMID 17337197, PMID 17400657, PMID 18405408, PMID 18757088, PMID 18849604, PMID 19054201, PMID 19155249, PMID 19168493, PMID 19195603, PMID 19249635, PMID 19351633, PMID 19398668, PMID 19464421, PMID 19477398, PMID 19685521, PMID 19812399, PMID 19942634, PMID 19958856, PMID 19958862, PMID 19959119, PMID 20019013, PMID 20109864, PMID 20116803, PMID 20117403, PMID 20138531, PMID 20348438, PMID 20362723, PMID 20634483, PMID 20660805, PMID 20736470, PMID 20837897, PMID 20844613, PMID 20876603, PMID 21093611, PMID 21111983, PMID 21126639, PMID 21146692, PMID 21168015, PMID 21247589, PMID 21392602, PMID 21450640, PMID 21464053, PMID 21624734, PMID 21840055

NIH funding

U01HL087318 (3), 2016 (2), 2005 (1), 2008 (1), 2009 (1), 2014 (1), 2015 (1), 2019 (1), 2023 (1), 5UM1HL087318 (1), K23HL148394 (1), P01HL076611 (1), R01HL091069 (1), R01HL149672 (1), R01HL165840 (1)